The European Medicines Agency (EMA) needs more information on Russian vaccine Sputnik-V against coronavirus, the head of biological health threats and the vaccine strategy told the regulator on Thursday, Marco Cavaleri.
The same goes for the Chinese vaccine Sinovac.
“As far as Sputnik V and Sinovac vaccines are concerned, there are a lot of productive discussions with the companies, but it seems that they need to be sent. more details, before progress can be made on certification process“, Said Cavaleri, according to the APE BPE.
It is recalled that the Sputnik-V vaccine is still under consideration by the EMA. Just last month an official of the organization assured that “we are in evaluation process of the formulation “as well as that” the approach is the same with all the vaccines and we are looking forward to the results “.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
